Colon News and Research

RSS

Addressing quality of life needs in prostate cancer: an interview with Professor Louis Denis

Modern patient-directed management is based on optimal, individual medical treatment and holistic personalised patient-centred care. This is certainly true in prostate cancer where most patients are over 60 years of age. They face a negative physical and functional impact from the diagnosis as well as from the treatment with emotional and social challenges.

4 Nov 2015

International research project examines effectiveness of tried and tested medicines for different diseases

The Medical University of Vienna is coordinating an international research project, which investigates the effectiveness of tried and tested medicines for the treatment of some of the heaviest burdens of our modern society including diseases such as cancer, diabetes and cardiovascular diseases. One molecule that these disorders have in common is a receptor known as the calcium-sensing receptor (CaSR), which is the molecular starting point of this project.

4 Nov 2015

Innovative immunotherapy clinical trial underway at The University of Kansas Cancer Center

A novel immunotherapy clinical trial underway now at The University of Kansas Cancer Center has enrolled the first patients in the world to receive what many doctors and researchers believe is the future of cancer treatment.

4 Nov 2015

Salk scientists uncover enzyme responsible for suppressing deadly lung cancer

Scientists at the Salk Institute have uncovered a molecule whose mutation leads to the aggressive growth of a common and deadly type of lung cancer in humans.

3 Nov 2015

CarePoint Health – Bayonne Medical Center named ACR-designated center for lung cancer screening

CarePoint Health, a fully integrated healthcare system that provides quality, patient-focused healthcare to residents of the Hudson County region, today announced that CarePoint Health – Bayonne Medical Center has been named an American College of Radiology designated center for lung cancer screening, making it the second facility in Hudson County (after CarePoint Health – Christ Hospital) to receive this designation.

31 Oct 2015

Cologuard stool DNA test: An accurate screening option for Alaska Native people with colorectal cancer

Cologuard stool DNA testing for colorectal cancer was found to be an accurate noninvasive screening option for Alaska Native people, a population with one of world's highest rates of colorectal cancer, concluded researchers from the Alaska Native Tribal Health Consortium and Mayo Clinic.

31 Oct 2015

Low-dose occupational radiation exposure increases solid cancer risk

Results of the International Nuclear Workers Study suggest a linear increase in incidence of solid cancers with increasing exposure to radiation.

30 Oct 2015

University of Kansas professor recognized with MERIT Award

Emily Scott, professor of medicinal chemistry at the University of Kansas, has been recognized with a MERIT Award from the National Institutes of Health's National Institute of General Medical Sciences. It's a rare and important recognition -- researchers can receive them only once in a career.

30 Oct 2015

Research focuses on understanding racial, ethnic disparities in colon cancer outcomes

Blase Polite, MD, has expertise in the treatment of gastrointestinal malignancies, with a particular focus on colon, rectal, and anal cancers, and neuroendocrine (carcinoid) tumors.

27 Oct 2015

New approaches to treating lung cancer patients in New Mexico

This year, more than 158,000 Americans are expected to die from lung cancer. That's a staggering number: it's more than all the deaths expected from breast, prostate, colon, rectum, bladder and skin cancers combined.

26 Oct 2015

PCF announces 19 new Young Investigator Awards

The Prostate Cancer Foundation announced 19 new Young Investigator (YI) Awards at the 22nd Annual Scientific Retreat in Washington, DC, held October 8-10, 2015. Awardees were selected from a pool of 107 applicants from 65 institutions in 9 countries.

22 Oct 2015

Latest research on thyroid cancer to be highlighted at 15th International Thyroid Congress

The effect of radiation exposure related to the nuclear accidents that took place in Fukushima, Japan, and Chernobyl, Ukraine on thyroid cancer risk, whether dietary habits influence the risk of developing thyroid cancer, and recent study results with a triiodothyronine (T3) analog in an uncommon form of thyroid disease are all topics featured in oral presentations delivered at the 15th International Thyroid Congress, hosted by the American Thyroid Association, October 18-23, 2015, in Orlando, Florida.

19 Oct 2015

Study could lead to better understanding of metabolic processes behind type 2 diabetes

Scientists in Sweden have discovered that human intestinal flora regulates the levels of the body's main antioxidant, glutathione, which fights a host of diseases. The findings could lead to new probiotic-delivering foods, and a better understanding of the metabolic processes behind diseases such as type 2 diabetes.

19 Oct 2015

NCCN reveals new value initiative for CML and Multiple Myeloma

The National Comprehensive Cancer Network, a not-for-profit alliance of 26 of the world's leading cancer centers, today unveiled its new value initiative—the NCCN Evidence Blocks, published within new versions of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Chronic Myelogenous Leukemia (CML) and Multiple Myeloma.

19 Oct 2015

CNIO researchers identify molecular mechanisms that determine cancer predisposition in DBA patients

Researchers from the Tumour Suppression Group at the Spanish National Cancer Research Centre, headed by Manuel Serrano, have discovered the molecular mechanisms that determine cancer predisposition in patients with Diamond-Blackfan anaemia (DBA).

18 Oct 2015

Study highlights need for dietary interventions in cancer survivors

While most cancer survivors in the United States are motivated to seek information about food choices and dietary changes to improve their health, a new study comparing their dietary patterns to federal guidelines indicates that they often fall short.

13 Oct 2015

Cancer survival outcomes can vary widely among U.S. hospitals

Decades of research have shown that cancer survival outcomes can vary widely depending on where patients receive care. But efforts to rank hospitals by long-term survival rates have been hindered by the readily available administrative data derived from Medicare claims, which lacks information about cancer stage. Two hospitals providing equally good care may have different survival rates if one hospital treats sicker patients, for example.

12 Oct 2015

FDA approves Opdivo to treat patients with advanced non-small cell lung cancer

The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) non-small cell lung cancer whose disease progressed during or after platinum-based chemotherapy.

11 Oct 2015

FDA grants accelerated approval for Keytruda to treat patients with advanced NSCLC

The U.S. Food and Drug Administration today granted accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC) whose disease has progressed after other treatments and with tumors that express a protein called PD-L1. Keytruda is approved for use with a companion diagnostic, the PD-L1 IHC 22C3 pharmDx test, the first test designed to detect PD-L1 expression in non-small cell lung tumors.

9 Oct 2015

New book suggests ways to reduce medical reversals

Medical reversal—when accepted medical interventions are abandoned because they are found to be ineffective—is the "most important problem in medicine today," according to the authors of a new book: Ending Medical Reversal.

8 Oct 2015

Colon News and Research

Addressing quality of life needs in prostate cancer: an interview with Professor Louis Denis

International research project examines effectiveness of tried and tested medicines for different diseases

Innovative immunotherapy clinical trial underway at The University of Kansas Cancer Center

Salk scientists uncover enzyme responsible for suppressing deadly lung cancer

CarePoint Health – Bayonne Medical Center named ACR-designated center for lung cancer screening

Cologuard stool DNA test: An accurate screening option for Alaska Native people with colorectal cancer

Low-dose occupational radiation exposure increases solid cancer risk

University of Kansas professor recognized with MERIT Award

Research focuses on understanding racial, ethnic disparities in colon cancer outcomes

New approaches to treating lung cancer patients in New Mexico

PCF announces 19 new Young Investigator Awards

Latest research on thyroid cancer to be highlighted at 15th International Thyroid Congress

Study could lead to better understanding of metabolic processes behind type 2 diabetes

NCCN reveals new value initiative for CML and Multiple Myeloma

CNIO researchers identify molecular mechanisms that determine cancer predisposition in DBA patients

Study highlights need for dietary interventions in cancer survivors

Cancer survival outcomes can vary widely among U.S. hospitals

FDA approves Opdivo to treat patients with advanced non-small cell lung cancer

FDA grants accelerated approval for Keytruda to treat patients with advanced NSCLC

New book suggests ways to reduce medical reversals

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News